How much disclosure is enough for a new estimation algorithm?

What is a product line claim, you ask?

Creative constraint theory applied to obviousness at the USPTO

If you are going to include annotated figures in your Office action correspondence, whether you are the patent applicant or the examiner, make sure the submissions are legible.

System claims cannot include method steps but can method claims include structural features?

How similar is sufficiently similar for KSR obviousness?

Is the goal of issuing only clear and inventive patents one that should trump all other issues?

Examiner obfuscation of a rejection does not play well at the PTAB

Just because something is called “typical” does not mean its scope is clear to the USPTO.

An example of how to ensure proper consideration of AFCP requests.